GARRETT KELLOGG: Open Payments
NPI 1467136218 · KINSMAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 38 payments from 17 companies in 2025. Trend: 2023 $528 · 2024 $3,197 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $197 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| PFIZER INC. | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| Novo Nordisk Inc | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $30 |
Products named: Adempas, JARDIANCE, LEQVIO, VYNDAQEL, Kerendia, CAMZYOS, EVKEEZA, AMVUTTRA.
Industry payments across OH — which companies pay providers there.
